• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Stayble Therapeutics

Less than 1K followers
Overview
Investor consensus
All
Press releases
3rd party
ShowingAll content types

Regulatory press release6/3/2026, 3:29 PM

Nasdaq beslutar om avnotering av Stayble Therapeutics från First North Growth Market

Stayble Therapeutics
Regulatory press release6/2/2026, 3:14 PM

Göteborgs Tingsrätt godkänner konkursansökan för Stayble Therapeutics AB (publ)

Stayble Therapeutics
Regulatory press release6/2/2026, 10:30 AM

Stayble Therapeutics ansöker om konkurs

Stayble Therapeutics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/28/2026, 1:56 PM

Stayble Therapeutics AB flyttar datum för årsredovisning

Stayble Therapeutics
Regulatory press release5/22/2026, 1:27 PM

Kallelse till årsstämma i Stayble Therapeutics AB (publ)

Stayble Therapeutics
Regulatory press release5/21/2026, 5:30 AM

Stayble Therapeutics offentliggör kvartalsrapport för första kvartalet 2026

Stayble Therapeutics
Regulatory press release5/7/2026, 8:44 PM

Styrelseledamot i Stayble Therapeutics AB avgår på egen begäran

Stayble Therapeutics
Regulatory press release5/7/2026, 11:51 AM

Kommuniké från extra bolagsstämma (tillika första kontrollstämma) i Stayble Therapeutics

Stayble Therapeutics
Regulatory press release5/6/2026, 9:17 PM

Stayble Therapeutics AB har ingått en avsiktsförklaring med en internationell strategisk investerare för fortsatt finansiering av verksamheten

Stayble Therapeutics
Regulatory press release5/5/2026, 6:00 AM

Stayble Therapeutics AB flyttar datum för årsstämma och årsredovisning

Stayble Therapeutics
Press release4/29/2026, 7:37 PM

Stayble Therapeutics: Stayble ger uppdatering inför extra bolagsstämma 7 maj 2026

Stayble Therapeutics
Regulatory press release4/17/2026, 5:39 PM

Kallelse till extra bolagsstämma tillika första kontrollstämma i Stayble Therapeutics AB (publ)

Stayble Therapeutics
Regulatory press release4/17/2026, 11:54 AM

Kontrollbalansräkning utvisar att det egna kapitalet i Stayble Therapeutics AB understiger hälften av det registrerade aktiekapitalet och styrelsen kommer att kalla till en första kontrollstämma

Stayble Therapeutics
Regulatory press release4/13/2026, 7:00 PM

Stayble Therapeutics beslutar att upprätta kontrollbalansräkning

Stayble Therapeutics
Press release3/2/2026, 12:45 PM

Kalqyl: Stayble Therapeutics: Rapportkommentar Q4'25

Stayble Therapeutics
Press release3/2/2026, 12:30 PM

Kalqyl: Stayble Therapeutics: VD-intervju med Andreas Gerward om Q4'25

Stayble Therapeutics
Regulatory press release2/25/2026, 7:45 AM

Stayble Therapeutics offentliggör bokslutskommuniké för 2025

Stayble Therapeutics
Press release11/25/2025, 11:05 AM

Kalqyl: Stayble Therapeutics: VD-intervju med Andreas Gerward om Q3'25

Stayble Therapeutics
Press release11/25/2025, 10:45 AM

Kalqyl: Stayble Therapeutics: Rapportkommentar Q3'25

Stayble Therapeutics
Regulatory press release11/19/2025, 6:45 AM

Stayble Therapeutics offentliggör kvartalsrapport för tredje kvartalet 2025

Stayble Therapeutics